
5274. urinary excretion estrone, 
estradiol estriol patients 
prostatic cancer benign prostatic 
hypertrophy 
hopkins c.e. 
urinary estrone, estradiol, estriol 
fractions excreted 21 patients 
prostatic cancer, 17 patients benign 
hypertrophy, 59 clinically well 
subjects assayed determine whether 
differences exist.  absolute levels 
estrone, estradiol, estriol fractions 
significantly different.  
excretion relatively lower levels estrone 
estradiol, relatively higher 
levels estriol patients prostatic 
cancer compared clinically well 
subjects resulted significantly lower 
proportions total estrogen 
excreted estrone estradiol.  differences 
proportions estrogen frac- 
tions patients benign hypertrophy 
clinically well subjects 
significant.  exception significantly 
higher percentage total 
estrogen excreted estrone patients 
benign hypertrophy, 
differences group cancer 
group also significant. 
clinical variations 3 groups, 
within cancer hypertrophy 
groups, preclude assignment significant 
differences prostatic dystrophies 
alone.  cancer patients experiencing inanition 
due loss appetite excreted 
significantly lower levels estrone patients 
reported loss appetite. 
significantly lower levels estrone excreted 
patients benign hyper- 
trophy hospitalized 6 days compared 
patients hospitalized 5 days less. 
significantly higher urinary estrone-androsterone 
ratio present cancer 
group clinically well group.  
believed, however, arbi- 
trary ratio can used suggest internal 
estrogen-androgen imbalance. 
